{"result": "(\"entity\"<|>GASTROESOPHAGEAL CANCER<|>EVENT<|>Gastroesophageal cancer is a type of cancer that affects the esophagus and stomach, often requiring surgical intervention and nutritional support for patients.)\n##\n(\"entity\"<|>NEOADJUVANT CHEMOTHERAPY<|>EVENT<|>Neoadjuvant chemotherapy is a treatment given before surgery to shrink tumors in patients with advanced esophageal cancer.)\n##\n(\"entity\"<|>ESOPHAGECTOMY<|>EVENT<|>Esophagectomy is a surgical procedure to remove part or all of the esophagus, often performed on patients with esophageal cancer.)\n##\n(\"entity\"<|>NUTRITIONAL STATUS<|>EVENT<|>Nutritional status refers to the condition of the body in relation to the intake and utilization of nutrients, which is critical for cancer patients undergoing treatment.)\n##\n(\"entity\"<|>CANCER CACHEXIA<|>EVENT<|>Cancer cachexia is a syndrome characterized by weight loss, muscle wasting, and decreased appetite in cancer patients, significantly impacting their quality of life.)\n##\n(\"entity\"<|>ARTIFICIAL NUTRITIONAL SUPPORT<|>EVENT<|>Artificial nutritional support involves providing nutrition through methods such as tube feeding, especially for cancer patients post-surgery.)\n##\n(\"entity\"<|>DYSphagia<|>EVENT<|>Dysphagia is a medical term for difficulty in swallowing, which can occur in patients with esophageal cancer.)\n##\n(\"entity\"<|>MARTIN LAGERGREN<|>PERSON<|>Martin Lagergren is a researcher involved in studies related to esophageal cancer and its treatment outcomes.)\n##\n(\"entity\"<|>JOURNAL OF GASTROINTESTINAL SURGERY<|>ORGANIZATION<|>The Journal of Gastrointestinal Surgery publishes research and studies related to surgical practices and outcomes in gastrointestinal diseases, including cancer.)\n##\n(\"entity\"<|>BRITISH JOURNAL OF CANCER<|>ORGANIZATION<|>The British Journal of Cancer is a peer-reviewed medical journal that publishes research on cancer treatment and outcomes.)\n##\n(\"relationship\"<|>NEOADJUVANT CHEMOTHERAPY<|>ESOPHAGECTOMY<|>Neoadjuvant chemotherapy is often administered to patients before esophagectomy to improve surgical outcomes<|>8)\n##\n(\"relationship\"<|>CANCER CACHEXIA<|>NUTRITIONAL STATUS<|>Cancer cachexia significantly affects the nutritional status of patients, leading to weight loss and muscle wasting<|>7)\n##\n(\"relationship\"<|>ARTIFICIAL NUTRITIONAL SUPPORT<|>ESOPHAGECTOMY<|>Artificial nutritional support is often required for patients after esophagectomy to ensure adequate nutrient intake<|>9)\n##\n(\"relationship\"<|>DYSphagia<|>NEOADJUVANT CHEMOTHERAPY<|>Dysphagia can be a complication in patients undergoing neoadjuvant chemotherapy for esophageal cancer<|>6)\n##\n(\"relationship\"<|>MARTIN LAGERGREN<|>BRITISH JOURNAL OF CANCER<|>Martin Lagergren has published research in the British Journal of Cancer regarding esophageal cancer treatment<|>5)\n##\n(\"relationship\"<|>MARTIN LAGERGREN<|>JOURNAL OF GASTROINTESTINAL SURGERY<|>Martin Lagergren has contributed to the Journal of Gastrointestinal Surgery with studies on surgical outcomes in esophageal cancer<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: al. The influence of syste-                        24:998-1005.\n     mic inflammation, dietary intake and stage of disea-                  76.   Jack S, West MA, Raw D, Marwood S, Ambler G,\n     se on rate of weight loss in patients with gastro-oe-                       Cope TM, et al. The effect of neoadjuvant chemo-\n     sophageal cancer. Br J Cancer. 2009; 100:63-9.                              therapy on physical fitness and survival in patients\n65.  Da Silva JB, Maurício SF, Bering T, Correia MI. The                         undergoing oesophagogastric cancer surgery. Eur\n     relationship between nutritional status and the                             J Surg Oncol. 2014;40:1313-20.\n---\n 632      BLOQUE: NUTRICIÓN EN ONCOLOGÍA\n\n\n\n77.   Ida S, Watanabe M, Karashima R, Imamura Y, Ishi-                   89.  Barlow R, Price P, Reid TD, Hunt S, Clark GW, Ha-\n      moto T, Baba Y, et al. Changes in body composi-                         vard TJ, Puntis MC, Lewis WG. Prospective multi-\n      tion secondary to neoadjuvant chemotherapy for                          centre randomised controlled trial of early ente-\n      advanced esophageal cancer are related to the oc-                       ral nutrition for patients undergoing major upper\n      currence of postoperative complications after eso-                      gastrointestinal      surgical    resection.     Clin   Nutr.\n      phagectomy. Ann Surg Oncol. 2014; 21:3675-9.                            2011; 30:560-6.\n78.   Tuca A, Jimenez-Fonseca P, Gascón P. Clinical eva-                 90.  Wright GP, Foster SM, Chung MH. Esophagec-\n      luation and optimal management of cancer ca-                            tomy in patients with prior percutaneous endos-\n      chexia. Crit Rev Oncol Hematol. 2013; 88:625-36.                        copic gastrostomy tube placement. Am J Surg.\n79.   Miller KR, Bozeman MC. Nutrition therapy issues in                      2014; 207:361-5.\n      esophageal cancer. Curr Gastroenterol Rep. 2012;                   91.  Choi AH, O’Leary MP, Merchant SJ, Sun V, Chao\n      14:356-66.                                                              J, Raz DJ, et al. Complications of Feeding Jejunos-\n80.   Mariette C, De Botton ML, Piessen G. Surgery in                         tomy Tubes in Patients with Gastroesophageal\n      esophageal and gastric cancer patients: what is                         Cancer. J Gastrointest Surg. 2017; 21:259-65.\n      the role for nutrition support in your daily practi-               92.  Bowen TS, Schuler G, Adams V. Skeletal muscle\n      ce? Ann Surg Oncol. 2012; 19:2128-34.                                   wasting in cachexia and sarcopenia: molecular\n81.   Llop-Talaveron JM, Farran-Teixidor L, Badia-Tahull                      pathophysiology and impact of exercise training.\n      MB, Virgili-Casas M, Leiva-Badosa E, Galán-Guz-                         J Cachexia Sarcopenia Muscle. 2015; 6:197-207.\n      mán MC, et al. Artificial nutritional support in can-              93.  Lønbro S. The effect of progressive resistance tra-\n      cer patients after esophagectomy: 11 years of ex-                       ining on lean body mass in post-treatment can-\n      perience. Nutr Cancer. 2014; 66:1038-46.                                cer patients - a systematic review. Radiother On-\n82.   Cools-Lartigue J, Jones D, Spicer J, Zourikian T,                       col. 2014; 110:71-80.\n      Rousseau M, Eckert E, et al. Management of Dys-                    94.  Martin L, Lagergren P. Risk factors for weight loss\n      phagia in Esophageal Adenocarcinoma Patients                            among patients surviving 5           years after esopha-\n      Undergoing Neoadjuvant Chemotherapy: Can In-                            geal cancer surgery. Ann Surg Oncol. 2015; 22:\n      vasive Tube Feeding be Avoided? Ann Surg Oncol.                         610-6.\n      2015; 22:1858-65.                                                  95.  Martin L, Lagergren P. Long-term weight chan-\n83.   Fietkau R, Lewitzki V, Kuhnt T, Hölscher T, Hess CF,                    ge after oesophageal cancer surgery. Br J Surg.\n      Berger B, et al. A disease-specific enteral nutrition                   2009; 96:1308-14.\n      formula improves nutritional status and functional                 96.  D’Journo XB, Ouattara M, Loundou A, Trousse D,\n      performance in patients with head and neck and                          Dahan L, Nathalie T, et al. Prognostic impact of\n      esophageal cancer undergoing chemoradiothera-                           weight loss in 1-year survivors after tran\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}